Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Peakstone Realty Trust
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Accelerated Transformation To Industrial Outdoor Storage Will Deliver Superior Returns
Key Takeaways Strategic portfolio shift to industrial outdoor storage assets and active office disposals strengthens long-term earnings potential, operating margins, and capital efficiency. Lower redevelopment costs and effective deleveraging improve financial flexibility, supporting faster growth and positioning for acquisition opportunities.
View narrative
US$14.67
FV
17.6% undervalued
intrinsic discount
-1.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
3 days ago
author updated this narrative
Theravance Biopharma
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Clinical Milestones And Patent Extensions Will Secure Future Expansion
Key Takeaways Accelerating demand for key respiratory therapies and strong royalty income support sustained revenue growth and improved earnings visibility. Strategic focus on targeted therapies, intellectual property protection, and operational efficiency boosts margins and long-term earnings stability.
View narrative
US$17.20
FV
33.0% undervalued
intrinsic discount
26.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Global Medical REIT
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Discounted Outpatient Properties Will Unlock Healthcare Real Estate Potential
Key Takeaways Acquisition of outpatient medical properties below market rates and successful re-tenanting are expected to drive rent, occupancy, and earnings growth. Favorable healthcare demographics and disciplined capital management are supporting stable demand, higher margins, and sustained long-term value creation.
View narrative
US$9.09
FV
27.8% undervalued
intrinsic discount
3.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
3 days ago
author updated this narrative
ZKH Group
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
China Digital Procurement And AI Adoption Will Expand Global Markets
Key Takeaways Digital platform strategy and AI-driven solutions drive efficiency, strengthen customer retention, and enable higher-margin sales, supporting robust earnings and margin expansion. Expansion into international and high-growth sectors diversifies revenue, enhances operational scale, and reduces risk, providing a foundation for sustained, profitable growth.
View narrative
US$4.23
FV
29.0% undervalued
intrinsic discount
10.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Auna
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
High-Efficiency Healthcare Model And Demographic Trends Will Shape Future Landscape
Key Takeaways Operational challenges in Mexico are being addressed, while strong performance in Peru showcases the potential of Auna's value-based, integrated care model. Investments in specialty services and payer diversification are expected to drive long-term revenue growth, higher margins, and stable, predictable cash flows.
View narrative
US$12.37
FV
49.7% undervalued
intrinsic discount
7.13%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Marcus
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Renovated Hotels And Cinematic Upgrades Will Unlock Value
Key Takeaways Hotel renovations and group booking momentum are expected to drive higher occupancy, revenues, and improve earnings visibility through increased experiential demand. Strategic upgrades in cinema offerings, targeted price adjustments, and disciplined capital allocation should boost per-patron spend, ancillary income, and long-term shareholder returns.
View narrative
US$24.50
FV
40.3% undervalued
intrinsic discount
4.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Gannett
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
AI Deals And Snowflake Partnerships Will Drive Gains Amid Risks
Key Takeaways AI partnerships and digital initiatives are fueling new revenue streams, improved ad targeting, and operational efficiency, driving stronger margins and reduced costs. Growth in digital subscriptions and trusted local content is boosting audience engagement and helping capture a larger share of local advertising budgets.
View narrative
US$5.76
FV
32.5% undervalued
intrinsic discount
-3.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
3 days ago
author updated this narrative
Axogen
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
FDA Approval And Improved Coverage Will Unlock Nerve Repair Markets
Key Takeaways Expanding market adoption, payer coverage, and strategic investments position the company for sustained growth, operational leverage, and improved margins. FDA approval for Avance Nerve Graft is set to provide market exclusivity, pricing power, and protection from competition, boosting long-term earnings visibility.
View narrative
US$24.71
FV
43.8% undervalued
intrinsic discount
16.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
3 days ago
author updated this narrative
InnovAge Holding
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Expanding US Senior Care Integration Will Drive Healthcare Transformation
Key Takeaways Enrollment growth and efficient geographic expansion are positioning the company for sustained revenue gains and scalable growth. Operational improvements and alignment with value-based care are driving margin improvements and better medical expense control.
View narrative
US$5.00
FV
33.8% undervalued
intrinsic discount
10.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Value any company in seconds
Popular companies